Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.14 USD | -3.48% | -7.18% | -15.42% |
04-12 | Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing | MT |
04-04 | Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.42% | 570M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- AVTE Stock
- News Aerovate Therapeutics, Inc.
- Aerovate Therapeutics : Cowen Initiates Coverage on Aerovate Therapeutics With Outperform Rating